Abstract 7555: Selective inhibition of the CoREST complex as a novel therapeutic target of atypical teratoid rhabdoid tumors
Anupa Geethadevi(Bloomberg (United States)), Eric H. Raabe(Johns Hopkins University), Philip A. Cole(Brigham and Women's Hospital), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Marianne Collard(Boston University), Robert Fisher(Boston University), Jeffrey Rubens(Johns Hopkins University), Rhoda M. Alani(Boston University), Yiming Deng, Nikhil Vaidya(Boston University), Tyler Findlay(Johns Hopkins University)
Cited by 0
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor
|Cell|2006|1.6k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k